Nicole Germino
Stock Analyst at Truist Securities
(0.44)
# 2496
Out of 5,344 analysts
30
Total ratings
37.50%
Success rate
-4.30%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Maintains: Buy | 18 14 | 4.32 | 224.07% | 3 | May 14, 2025 | |
CATX Perspective Therapeu... | Maintains: Buy | 10 8 | 2.4 | 233.33% | 3 | May 14, 2025 | |
INSM Insmed | Maintains: Strong Buy | 105 108 | 67.55 | 59.88% | 8 | Feb 21, 2025 | |
SGMO Sangamo Therapeutics | Maintains: Buy | 7 5 | 0.47 | 963.83% | 5 | Jan 23, 2025 | |
FUSN Fusion Pharmaceutica... | Downgrades: Hold | 11 21 | n/a | n/a | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 13 13 | n/a | n/a | 3 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 132 24 | 13.63 | 76.08% | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2021 |